In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus
- PMID: 17905979
- PMCID: PMC2223566
- DOI: 10.1128/JB.00912-07
In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus
Abstract
Trimethoprim-sulfamethoxazole (SXT)-resistant Staphylococcus aureus thymidine-dependent small-colony variants (TD-SCVs) are frequently isolated from the airways of cystic fibrosis (CF) patients, often in combination with isogenic normal strains if patients were treated with SXT for extended periods. As SXT inhibits the synthesis of tetrahydrofolic acid, which acts as a cofactor for thymidylate synthase (thyA), the survival of TD-SCVs depends exclusively on the availability of external thymidine. Since the underlying mechanism for thymidine dependency is unknown, we investigated if alterations in the thyA nucleotide sequences were responsible for this phenomenon. Sequence analysis of several clinical TD-SCVs and their isogenic normal strains with reference to previously published S. aureus thyA nucleotide sequences was performed. Three clinical TD-SCVs were complemented by transforming TD-SCVs with the vector pCX19 expressing ThyA from S. aureus 8325-4. Transcriptional analysis of metabolic and virulence genes and regulators (agr, hla, spa, citB, thyA, and nupC) was performed by quantitative reverse transcription-PCR. The previously published sequences of thyA and two normal clinical strains were highly conserved, while thyA of four normal strains and four SCVs had nonsynonymous point mutations. In 8/10 SCVs, deletions occurred, resulting in stop codons which were located in 4/10 SCVs close to or within the active site of the protein (dUMP binding). Complementation of TD-SCVs with thyA almost fully reversed the phenotype, growth characteristics, and transcription patterns. In conclusion, we demonstrated that mutations of the thyA gene were responsible for the phenotype of TD-SCVs. Complementation of TD-SCVs with thyA revealed that a functional ThyA protein is necessary and sufficient to change the SCV phenotype and behavior back to normal.
Figures




Similar articles
-
Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge.Antimicrob Agents Chemother. 2015 Dec;59(12):7265-72. doi: 10.1128/AAC.00742-15. Epub 2015 Sep 14. Antimicrob Agents Chemother. 2015. PMID: 26369968 Free PMC article.
-
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.Antimicrob Agents Chemother. 2008 Jun;52(6):2183-9. doi: 10.1128/AAC.01395-07. Epub 2008 Mar 31. Antimicrob Agents Chemother. 2008. PMID: 18378706 Free PMC article.
-
Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression.mBio. 2014 Jul 29;5(4):e01447-14. doi: 10.1128/mBio.01447-14. mBio. 2014. PMID: 25073642 Free PMC article.
-
Small colony variants of Staphylococcus aureus--review.Folia Microbiol (Praha). 2010 Nov;55(6):548-58. doi: 10.1007/s12223-010-0089-3. Epub 2011 Jan 21. Folia Microbiol (Praha). 2010. PMID: 21253898 Review.
-
Small colony variants (SCVs) of Staphylococcus aureus--a bacterial survival strategy.Infect Genet Evol. 2014 Jan;21:515-22. doi: 10.1016/j.meegid.2013.05.016. Epub 2013 May 27. Infect Genet Evol. 2014. PMID: 23722021 Review.
Cited by
-
Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance.Antimicrob Agents Chemother. 2010 Oct;54(10):4522-3; author reply 5423-5. doi: 10.1128/AAC.00422-10. Antimicrob Agents Chemother. 2010. PMID: 20852189 Free PMC article. No abstract available.
-
Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.J Clin Microbiol. 2008 Nov;46(11):3829-32. doi: 10.1128/JCM.01440-08. Epub 2008 Oct 1. J Clin Microbiol. 2008. PMID: 18832128 Free PMC article.
-
PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.Antimicrob Agents Chemother. 2014 Nov;58(11):6668-74. doi: 10.1128/AAC.03622-14. Epub 2014 Aug 25. Antimicrob Agents Chemother. 2014. PMID: 25155594 Free PMC article.
-
The Complex Intracellular Lifecycle of Staphylococcus aureus Contributes to Reduced Antibiotic Efficacy and Persistent Bacteremia.Int J Mol Sci. 2024 Jun 12;25(12):6486. doi: 10.3390/ijms25126486. Int J Mol Sci. 2024. PMID: 38928191 Free PMC article. Review.
-
Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.J Pediatric Infect Dis Soc. 2022 Sep 7;11(Supplement_2):S23-S31. doi: 10.1093/jpids/piac073. J Pediatric Infect Dis Soc. 2022. PMID: 36069898 Free PMC article. Review.
References
-
- Besier, S., A. Ludwig, K. Ohlsen, V. Brade, and T. A. Wichelhaus. 2007. 2007. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int. J. Med. Microbiol. 297217-225. - PubMed
-
- Carreras, C. W., and D. V. Santi. 1995. The catalytic mechanism and structure of thymidylate synthase. Annu. Rev. Biochem. 64721-762. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials